Cisplatin-resistant HepG2 cell-derived exosomes transfer cisplatin resistance to cisplatin-sensitive cells in HCC

Cisplatin-resistant HepG2 cell-derived exosomes transfer cisplatin resistance to cisplatin-sensitive cells in HCC

Backgrounds Cancer cell resistance to chemotherapy drugs such as Gemcitabine, Oxaliplatin, Cisplatin, Doxorubicin, and 5-fluorouracil account for the main reason of chemotherapy failure for HCC patients, especially for those with advanced HCC or metastasis patients. This emerging resistance limits t...

Descripción completa

Detalles Bibliográficos
Autores principales: Zuxiong Tang, Jun He, Jiayue Zou, Shufei Yu, Xiaoming Sun, Lei Qin
Formato: Artículo
Lenguaje:English
Publicado: PeerJ Inc. 2021-04-01
Colección:PeerJ
Materias:
Drug resistance
Cell viability
Acceso en línea:https://peerj.com/articles/11200.pdf

Ejemplares similares

Ejemplares similares